Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale to help predict patient response to immunotherapy and expand access to advanced cancer research worldwide.
microsoftimmunotherapycancer researchAI in healthcarecancer immunotherapymedical AIcancer diagnosticsoncology researchAI for cancerbiomedical AIMicrosoft FoundryGigaTIMEcancer treatment innovationAI drug discoveryclinical research AIUniversity of Washington research